Global /China /Healthcare /Biotechnology /688217

Shanghai Rightongene Biotechnology Co., Ltd.

688217

• SSE: 688217 • Delayed

28.93CNY 0.2%

4.27 USD

As of 14 June 2026, Shanghai Rightongene Biotechnology Co., Ltd. has a market cap of $235.62M USD, ranking #20057 globally and #5688 in China. It ranks #1805 in the Healthcare sector, and #348 in the Biotechnology industry.

Global Rank

20057

Country Rank

5688

Sector Rank

1805

Industry Rank

348

Key Stats

Market Cap

$235.62MUSD

1.6B CNY

Enterprise Value

$202.83MUSD

1.37B CNY

Revenue (TTM)

$24.03MUSD

162.81M CNY

EBITDA (TTM)

-$1.58MUSD

-10.7M CNY

Net Income (TTM)

-$8.67MUSD

-58.72M CNY

EBITDA Margin

-6.6%

Profit Margin

-36%

PS Ratio

9.8

PB Ratio

1.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Shangxian Gao open_in_new

Employees

385

Founded

2012

Website

rightongene.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.2%	4.1%	4%	-1.4%	2.5%	9.8%	37%	-33%	-76%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688217 上海睿昂基因科技股份有限公司 Class A ISIN: CNE100005212 Shares Out.: Shares Outstanding: 55.186M¹ Shares Float: 55.182M² TV: TradingView: SSE: 688217 SA: Stock Analysis: SHA: 688217 YF: Yahoo Finance: 688217.SS GF: Google Finance: SHA: 688217 BA: Barron's: 688217 MS: Morningstar: XSHG: 688217	28.93 CNY	TV: TradingView: SSE: 688217 SA: Stock Analysis: SHA: 688217 YF: Yahoo Finance: 688217.SS GF: Google Finance: SHA: 688217 BA: Barron's: 688217 MS: Morningstar: XSHG: 688217

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai Rightongene Biotechnology Co., Ltd.

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases in China. The company offers self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 7K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 5K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.0B 54.23B CNY 3K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.33B 49.69B CNY 3K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 3K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 3K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 77K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 68K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 20K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 19K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 18K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 18K%	37.2	Switzerland

chevron_leftBack